- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
4164
SAU
Week ended 07 Aug 2026
Weekly Investor Report
Nahdi Medical Company · Healthcare · Pharmaceutical Retailers
Latest close
95.20 SAR
0.2%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -2.3% below the Trend Line and sits at 21.0% of its 52-week range. The latest completed week returned 0.2%, after a 3.6% four-week move. The latest news-sentiment score is 50/100.
Setup score
37
out of 100
Latest Close
95.20 SAR
7 Aug 2026
1W Return
0.2%
latest completed week
4W Return
3.6%
short-term follow-through
12W Return
-3.4%
quarterly tape
Trend Breadth
7.7%
4 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.2%
Latest completed week; four-week move 3.6%.
Indicator stack
4/42
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.15%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
8 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.3% below the Trend Line and sits at 21.0% of its 52-week range. The latest completed week returned 0.2%, after a 3.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0112-week average 0.20
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 3.6% over four weeks, -3.4% over 12 weeks, and -18.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year4
Trend breadth7.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.58Latest activity-pressure read.
Pressure change26.8%Four-week change in activity pressure.
Leadership-4.85Latest relative-leadership reading.
RS change50.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 8 relevant articles.
0 positive · 8 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-21.0%Distance below the 52-week high.
13-week volatility1.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2615 weeks finished lower.
Best week+8.8%Week of 13 Mar.
Worst week-4.8%Week of 24 Apr.
Latest week+0.2%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains8
Flat weeks1
Modest losses14
Sharp losses1
Recent vol1.8%13-week weekly-return volatility.
Base vol3.0%52-week weekly-return volatility.
Up/down split20/29Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSA Healthcare
4-week rank7 / 31
Group average0.0%
Trend breadth22.6%
Trend22.6%active weekly trend signals
MD29.0%positive activity pressure
RS19.4%positive relative leadership
Four-week leaders
IndustrySA Pharmaceutical Retailers
4-week rank2 / 4
Group average-2.9%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD25.0%positive activity pressure
RS25.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape32/100
Trend, activity pressure, participation, and risk combine to a 32/100 tape read.
Indicator analysis16/100Latest 12-week confirmation: trend 2/12, activity pressure 2/12, relative leadership 0/12.
Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 43.15%Next-week expectancy is negative with a 43.15% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 8 relevant articles.
Nahdi Medical Company (TADAWUL:4164) Just Released Its Second-Quarter Earnings: Here's What Analysts Think Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 95.20 SAR | 0.2% | 97.47 SAR | 113.8 SAR | -0.58 | -4.85 | 630.6K | Off |
| 31 Jul 2026 | 95.05 SAR | 4.3% | 97.28 SAR | 114.2 SAR | -0.73 | -3.14 | 918.2K | Off |
| 24 Jul 2026 | 91.15 SAR | 0.2% | 97.24 SAR | 114.6 SAR | -0.91 | -9.38 | 563.3K | Off |
| 17 Jul 2026 | 90.95 SAR | -1.0% | 97.29 SAR | 115.0 SAR | -0.89 | -9.49 | 458.4K | Off |
| 10 Jul 2026 | 91.90 SAR | -1.9% | 97.35 SAR | 115.4 SAR | -0.79 | -9.73 | 409.6K | Off |
| 3 Jul 2026 | 93.70 SAR | -0.4% | 97.47 SAR | 115.8 SAR | -0.67 | -8.59 | 439.0K | Off |
| 26 Jun 2026 | 94.05 SAR | -1.5% | 97.60 SAR | 116.1 SAR | -0.59 | -9.59 | 304.5K | Off |
| 19 Jun 2026 | 95.50 SAR | 1.4% | 97.68 SAR | 116.5 SAR | -0.45 | -10.22 | 612.7K | Off |
| 12 Jun 2026 | 94.20 SAR | -2.3% | 98.02 SAR | 116.9 SAR | -0.33 | -11.27 | 653.1K | Off |
| 5 Jun 2026 | 96.45 SAR | -2.0% | 98.40 SAR | 117.2 SAR | -0.16 | -9.05 | 461.6K | Off |
| 29 May 2026 | 98.45 SAR | 0.0% | 98.81 SAR | 117.6 SAR | 0.02 | -7.81 | 0 | On |
| 22 May 2026 | 98.45 SAR | -0.2% | 99.29 SAR | 118.0 SAR | 0.28 | -7.81 | 568.9K | On |
| 15 May 2026 | 98.60 SAR | -2.9% | 99.87 SAR | 118.4 SAR | 0.44 | -7.63 | 872.4K | Off |
| 8 May 2026 | 101.5 SAR | -3.3% | 100.5 SAR | 118.8 SAR | 0.64 | -5.44 | 413.7K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.